Trial Profile
Dapaglifozin in Type 2 Diabetes Mellitus Patients: A Single-centre Retrospective Cohort Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Oct 2018 Status changed to completed.
- 21 Nov 2016 New trial record